This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lu AA24493

H. Lundbeck A/S

Drug Names(s): Lu AA24493

Description: Lu AA24493 is a novel carbamoylatedform of human erythropoietin(EPO) – a modification of EPO that results inloss of haematopoietic effects but maintainsthe tissue protective effect.

Deal Structure: In February 2002, H. Lundbeck A/S licensed certain rights to Warren Pharmaceuticals' proprietary tissue protective technology, including licensing rights to Lu AA24493. Lundbeck holds worldwide rights for indications related to the central nervous system. Lundbeck has invested five million USD in Warren Pharmaceuticals.


Lu AA24493 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug